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level of educational effectiveness was on par with or greater than
previously received in-person DES training. This effectiveness
translated into greater content retention and higher motivation
to learn. A study review revealed that return on investment for
corporate online training approaches 30% in the ﬁrst 2 years of
deployment and more than 100 percent after 4-years. For both
DES professionals engaged in training, and students, travel and
accommodation costs were reduced to zero, while costs due to
lost workdays were reduced by 50% for students and 100% for
DES professionals. CONCLUSION: The capability to lower
training budgets for DES education removes a signiﬁcant barrier
to the diffusion of this modeling technique. The savings in both
cost and resources allows knowledgeable DES professionals to
invest in the creation of online courses without the expense and
difﬁculty of scheduling teaching sessions.
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OBJECTIVES: Importance of animal health economics has been
widely acknowledged. The objective of this project was to evalu-
ate the perspective and type of analyses used in animal health
economic studies. METHODS: An electronic search in EMBASE
and MEDLINE was conducted from 1987 onwards, using
the key words economic, cost-effectiveness, cost-beneﬁt, cost-
minimization, cost-cost analysis, combined with the respective
kind of animal (cow, pig, horse, dog, cat). Among 631 articles, 68
abstracts were included for this review (34 studies in cows, 13 in
pigs, 3 in horses, 14 in dogs, 4 in cats), the others did not
represent health economic studies. RESULTS: Study perspective
was stated in only one abstract but could be assumed from the
content in the other studies, being that of the animal owner in all
but one. Cost-effectiveness was the type of study most often used
(37/68), followed by cost-beneﬁt studies (22/68). Again, the kind
of study often had to be assumed as it was only mentioned in
22% of the abstracts (15/68). The main ﬁeld of investigation was
that of immunization. CONCLUSION: The fact that fundamen-
tal information on the perspective or type of study was rarely
stated in the abstracts might be due to the fact that guidelines on
animal health economics are missing. The predominant perspec-
tive, namely that of the animal owner differed from those found
in human health economics. It reﬂects the fact that insurance or
public coverage of costs is not widespread in animal health;
accordingly the owner is the main payer. If compared with
human health economics the share of cost-beneﬁt analyses was
higher, as there is a market price especially for farm animals and
their products. Further efforts in this ﬁeld might improve quality
of study presentation and probably raise interest for health eco-
nomic studies on veterinary pharmaceuticals.
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OBJECTIVES: The U.S. Centers for Medicare and Medicaid
Services (CMS) has adopted a Medicare quality incentive pay-
for-performance concept. This study explores CMS’s implemen-
tation of the Physician Quality Reporting Initiative (PQRI),
including measurement development, reporting guidelines and
the proposed methods by which physicians will be compensated
for participation. METHODS: PQRI guidance provided by CMS
was collected, arranged in order of issuance, abstracted and
analyzed. Ongoing corrections and modiﬁcations were noted as
appropriate. A compilation of suggested PQRI-relevant resources
was also created as part of the project. RESULTS: The Tax Relief
and Healthcare Act (TRHCA) Division B, Title I, Section 101
provides statutory authority for PQRI. The TRHCA deﬁnes
eligible professionals; quality measures themselves, as well as
reporting methods and processes for obtaining bonus payment.
The initial reporting period commences July 1, 2007 and ends
December 31, 2007. During this period 74 quality measures may
be reported. If 4 or more measures are applicable to the physician
practice, the practitioner must report at least 3 correctly for 80%
of applicable cases. If 3 or fewer measures are applicable to the
practice, the practitioner must report each of them correctly for
80% of the cases. Cases may be either visits or patients, depend-
ing upon the particular measure. Professionals that report
successfully are eligible for a 1.5% bonus payment (pay-for-
performance), subject to a cap. The bonus payment calculation
method is determined by using total allowed charges for covered
professional services that are furnished during the reporting
period and are paid under the CMS Physician Fee Schedule.
CONCLUSION: Physician practices must adhere to the appro-
priate method for coding and reporting quality measures in order
to obtain relevant bonus compensation. It is vital for physician
practice decision-makers to understand and comply with the
CMS reporting methodology in order to reap the accompanying
monetary compensation.
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OBJECTIVES: Greater emphasis for economic evaluations in
health care reimbursement decision-making has brought about
the need for models that are accurate and methodologically
sound. Although guidelines exist suggesting appropriate methods
for model validation, there remains a paucity of practical
guidance outlining steps to ensure that outcomes have been
appropriately validated. The objective was to establish a process
outlining a series of practical tests to ensure consistent model
validation. METHODS: A systematic search of the literature was
conducted to identify modeling guidelines and published model-
ing studies discussing validation techniques. Results from the
literature search were used to develop practical steps to ensure
consistent model validation. RESULTS: A list of validation tests
were compiled and collated following a review of 15 guideline
publications on model validation. Model validation should not
only encompass checking for calculation errors or structural
inconsistencies, but also include a complete synthesis of the
evidence-based data used to produce results. Initially, the model
structure should be reviewed for face validity, assessing the eco-
nomic and clinical assumptions that include consulting scientiﬁc
experts, external to the model development process. Secondly,
convergent validity should be conducted where a series of tests
are performed comparing if results from other independently
developed models draw similar conclusions. Internal validity
involves a series of procedures to ensure the basic model frame-
work and mathematical calculations are consistent. Test-runs
should be performed including a replication test, and extensive
sensitivity analyses, whereby a series of extreme/hypothetical
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